-
1
-
-
0032576759
-
Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C
-
Vento S, Garofano T, Renzini C, et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med. 1998;338:286-290.
-
(1998)
N Engl J Med
, vol.338
, pp. 286-290
-
-
Vento, S.1
Garofano, T.2
Renzini, C.3
-
2
-
-
0038053180
-
Who should receive hepatitis A vaccine?
-
Arankalle VA, Chadha MS. Who should receive hepatitis A vaccine? J Viral Hepat. 2003;10:157-158.
-
(2003)
J Viral Hepat
, vol.10
, pp. 157-158
-
-
Arankalle, V.A.1
Chadha, M.S.2
-
3
-
-
34147151237
-
Immunization of the HIV infected traveller
-
Chadwick DR, Geretti AM. Immunization of the HIV infected traveller. AIDS. 2007;21:787-794.
-
(2007)
AIDS
, vol.21
, pp. 787-794
-
-
Chadwick, D.R.1
Geretti, A.M.2
-
4
-
-
0030894881
-
The effect of immunization with inactivated hepatitis A vaccine on the clinical course of HIV-I infection: 1-year follow-up
-
Bodsworth NJ, Neilsen GA, Donovan B. The effect of immunization with inactivated hepatitis A vaccine on the clinical course of HIV-I infection: 1-year follow-up. AIDS. 1997;11:747-749.
-
(1997)
AIDS
, vol.11
, pp. 747-749
-
-
Bodsworth, N.J.1
Neilsen, G.A.2
Donovan, B.3
-
5
-
-
0345269168
-
Safety and immunogenicity of hepatitis A vaccine in human immunodeficiency virus-infected patients: A double-blind, randomized, placebo-controlled trial
-
Kemper CA, Haubrich R, Frank I, et al. Safety and immunogenicity of hepatitis A vaccine in human immunodeficiency virus-infected patients: a double-blind, randomized, placebo-controlled trial. J Infect Dis. 2003; 187:1327-1331.
-
(2003)
J Infect Dis
, vol.187
, pp. 1327-1331
-
-
Kemper, C.A.1
Haubrich, R.2
Frank, I.3
-
6
-
-
27144551779
-
Response to hepatitis A vaccine in HIV patients in the HAART era
-
Rimland D, Guest JL. Response to hepatitis A vaccine in HIV patients in the HAART era. AIDS. 2005;19:1702-1704.
-
(2005)
AIDS
, vol.19
, pp. 1702-1704
-
-
Rimland, D.1
Guest, J.L.2
-
7
-
-
33846967799
-
Predictors of immunity after hepatitis A vaccination in HIV-infected persons
-
Overton ET, Nurutdinova D, Sungkanuparph S, et al. Predictors of immunity after hepatitis A vaccination in HIV-infected persons. J Viral Hepat. 2007;14:189-193.
-
(2007)
J Viral Hepat
, vol.14
, pp. 189-193
-
-
Overton, E.T.1
Nurutdinova, D.2
Sungkanuparph, S.3
-
8
-
-
30944454860
-
Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy
-
Weinberg A, Gona P, Nachman SA, et al. Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy. J Infect Dis. 2006;193:302-311.
-
(2006)
J Infect Dis
, vol.193
, pp. 302-311
-
-
Weinberg, A.1
Gona, P.2
Nachman, S.A.3
-
9
-
-
0028928908
-
Clinical experience with an inactivated hepatitis Avaccine
-
Clemens R, Safary A, Hepburn A, et al. Clinical experience with an inactivated hepatitis Avaccine. J Infect Dis. 1995;171(Suppl 1):S44-S49.
-
(1995)
J Infect Dis
, vol.171
, Issue.SUPPL. 1
-
-
Clemens, R.1
Safary, A.2
Hepburn, A.3
-
10
-
-
0027745966
-
Safety, tolerability, and immunogenicity of an inactivated hepatitis A vaccine: Effects of single and booster injections, and comparison to administration of immune globulin
-
Shouval D, Ashur Y, Adler R, et al. Safety, tolerability, and immunogenicity of an inactivated hepatitis A vaccine: effects of single and booster injections, and comparison to administration of immune globulin. J Hepatol. 1993;18(Suppl 2):S32-S37.
-
(1993)
J Hepatol
, vol.18
, Issue.SUPPL. 2
-
-
Shouval, D.1
Ashur, Y.2
Adler, R.3
-
11
-
-
0026483854
-
Clinical assessment of the safety and efficacy of an inactivated hepatitis Avaccine: Rationale and summary of findings
-
Andre FE, D'Hondt E, Delem A, et al. Clinical assessment of the safety and efficacy of an inactivated hepatitis Avaccine: rationale and summary of findings. Vaccine. 1992;10(Suppl 1):S160-S168.
-
(1992)
Vaccine
, vol.10
, Issue.SUPPL. 1
-
-
Andre, F.E.1
D'Hondt, E.2
Delem, A.3
-
12
-
-
29044443174
-
Efficacy of inactivated hepatitis A vaccine in HIV-infected patients: A hierarchical bayesian meta-analysis
-
Shire NJ, Welge JA, Sherman KE. Efficacy of inactivated hepatitis A vaccine in HIV-infected patients: a hierarchical bayesian meta-analysis. Vaccine. 2006;24:272-279.
-
(2006)
Vaccine
, vol.24
, pp. 272-279
-
-
Shire, N.J.1
Welge, J.A.2
Sherman, K.E.3
-
13
-
-
12844269826
-
Safety and immunogenicity of an inactivated hepatitis A vaccine among HIV-infected subjects
-
Wallace MR, Brandt CJ, Earhart KC, et al. Safety and immunogenicity of an inactivated hepatitis A vaccine among HIV-infected subjects. Clin Infect Dis. 2004;39:1207-1213.
-
(2004)
Clin Infect Dis
, vol.39
, pp. 1207-1213
-
-
Wallace, M.R.1
Brandt, C.J.2
Earhart, K.C.3
-
14
-
-
0030219524
-
Hepatitis A vaccine responses in HIV-positive persons with haemophilia
-
Tilzey AJ, Palmer SJ, Harrington C, et al. Hepatitis A vaccine responses in HIV-positive persons with haemophilia. Vaccine. 1996;14:1039-1041.
-
(1996)
Vaccine
, vol.14
, pp. 1039-1041
-
-
Tilzey, A.J.1
Palmer, S.J.2
Harrington, C.3
-
15
-
-
0028059681
-
Patterns of immunogenicity of an inactivated hepatitis A vaccine in anti-HIV positive and negative hemophilic patients
-
Santagostino E, Gringeri A, Rocino A, et al. Patterns of immunogenicity of an inactivated hepatitis A vaccine in anti-HIV positive and negative hemophilic patients. Thromb Haemost. 1994;72:508-510.
-
(1994)
Thromb Haemost
, vol.72
, pp. 508-510
-
-
Santagostino, E.1
Gringeri, A.2
Rocino, A.3
-
16
-
-
0028343370
-
Influence of smoking on immunological responses to hepatitis B vaccine
-
Winter AP, Follett EA, Mclntyre J, et al. Influence of smoking on immunological responses to hepatitis B vaccine. Vaccine. 1994; 12: 771-772.
-
(1994)
Vaccine
, vol.12
, pp. 771-772
-
-
Winter, A.P.1
Follett, E.A.2
Mclntyre, J.3
|